Audrey Lardy-Cléaud

Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008–2016

Élise Deluche, Alison Antoine, Thomas Bachelot et al. · European Journal of Cancer · 2020 · 180 citations

Metastatic Breast Cancer, Breast Oncology, Cancer Epidemiology +9

Endocrine therapy or chemotherapy as first-line therapy in hormone receptor–positive HER2-negative metastatic breast cancer patients

Emmanuelle Jacquet, Audrey Lardy-Cléaud, Barbara Pistilli et al. · European Journal of Cancer · 2018 · 65 citations

First-line Therapy, Breast Oncology, Endocrine Oncology +10

NISCAHN: A phase II, multicenter nonrandomized trial aiming at evaluating nivolumab (N) in two cohorts of patients (pts) with recurrent/metastatic (R/M) salivary gland carcinoma of the head and neck (SGCHN), on behalf of the Unicancer Head & Neck Group.

Jérôme Fayette, Caroline Even, Laurence Digue et al. · Journal of Clinical Oncology · 2019 · 58 citations

Non-acc Pts, Phase Ii, Neck Group +15

<scp>PALLIA</scp>‐10, a screening tool to identify patients needing palliative care referral in comprehensive cancer centers: A prospective multicentric study (<scp>PREPA</scp>‐10)

Yann Molin, Caroline Gallay, Julien Gautier et al. · Cancer Medicine · 2019 · 53 citations · Full text

Metastatic inflammatory breast cancer: survival outcomes and prognostic factors in the national, multicentric, and real-life French cohort (ESME)

Domitille Dano, Audrey Lardy-Cléaud, Audrey Monneur et al. · ESMO Open · 2021 · 36 citations · Full text